Recommendations for the management of opioid-induced constipation - how to improve usability in clinical practice

References

• Sullivan MD, Edlund MJ, Fan MY, et al. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain. 2008 Aug 31;138(2):440–449. doi: 10.1016/j.pain.2008.04.027
   PubMed Web of Science ®Google Scholar
• Bosetti C, Santucci C, Radrezza S, et al. Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990–2016. Eur J Pain (United Kingdom). 2019;23(4):697–707. doi: 10.1002/ejp.1337
   PubMed Web of Science ®Google Scholar
• Argoff CE. Opioid-induced constipation: a review of health-related quality of life, patient burden, practical clinical considerations, and the impact of peripherally acting μ-opioid receptor antagonists. Clin J Pain. 2020 Sep 1;36(9):716–722. doi: 10.1097/AJP.0000000000000852
   PubMed Web of Science ®Google Scholar
• Coyne KS, Margolis MK, Yeomans K, et al. Opioid-induced constipation among patients with chronic noncancer pain in the United States, Canada, Germany, and the United Kingdom: laxative use, response, and Symptom burden over time. Pain Med. 2015 Aug 1;16(8):1551–1565. doi: 10.1111/pme.12724
   PubMed Web of Science ®Google Scholar
• Häuser W, Morlion B, Vowles KE, et al. European* clinical practice recommendations on opioids for chronic noncancer pain - part 1: role of opioids in the management of chronic noncancer pain. Eur J Pain. 2021 May 1;25(5):949–968. doi: 10.1002/ejp.1736
   PubMed Web of Science ®Google Scholar
• Varrassi G, Banerji V, Gianni W, et al. Impact and consequences of opioid-induced constipation: a survey of patients. Pain Ther. 2021;10(2):1139–1153. doi: 10.1007/s40122-021-00271-y
   PubMed Web of Science ®Google Scholar
• Crockett SD, Greer KB, Heidelbaugh JJ, et al. American Gastroenterological Association Institute guideline on the medical management of opioid-induced constipation. Gastroenterology. 2019 Jan 1;156(1):218–226. doi: 10.1053/j.gastro.2018.07.016
   PubMed Web of Science ®Google Scholar
• Farmer AD, Drewes AM, Chiarioni G, et al. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. UEG J. 2019 Feb 1;7(1):7–20. doi: 10.1177/2050640618818305
   Google Scholar
• Keller MS, Jusufagic A, Spiegel BMR. Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study. BMC Gastroenterol. 2019 Nov 12;19(1). doi: 10.1186/s12876-019-1097-7
   PubMed Web of Science ®Google Scholar
• Vallerand AH, Hendry S, Baldys E, et al. Analysis of patient-provider interactions regarding the burden and treatment of opioid-induced constipation in adults with chronic noncancer pain. Pain Med. 2019 May 1;20(5):889–896. doi: 10.1093/pm/pny151
   PubMed Web of Science ®Google Scholar
• Bassotti G, Satta PU, Bellini M. Chronic idiopathic constipation in adults: a review on current guidelines and emerging treatment options. Clin Exp Gastroenterol. 2021;14:413–428. doi: 10.2147/CEG.S256364
   PubMed Web of Science ®Google Scholar
• Rekatsina M, Paladini A, Drewes AM, et al. Efficacy and safety of peripherally acting μ-opioid receptor antagonist (PAMORAs) for the management of patients with opioid-induced constipation: a systematic review. Cureus. 2021 Jul 6;13(7). doi: 10.7759/cureus.16201
   Web of Science ®Google Scholar
• Hale ME, Wild JE, Yamada T, et al. Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives. Therap Adv Gastroenterol. 2021;14:14. doi: 10.1177/17562848211032320
   Web of Science ®Google Scholar
• Gudin J, Vu L, Ceschim MR, et al. Peripherally acting mu-opioid receptor antagonists for the treatment of opioid-induced constipation. Aliment Pharmacol Ther. 2022 May 1;55(S2):S8–15. doi: 10.1111/apt.16864
   PubMedGoogle Scholar
• Olesen AE, Gronlund D, Mark EB, et al. Effects of naloxegol on gastrointestinal transit and colonic fecal volume in healthy participants receiving oxycodone. J Neurogastroenterol Motil. 2019 Oct 1;25(4):602–610. doi: 10.5056/jnm18079
   PubMed Web of Science ®Google Scholar
• Grønlund D, Poulsen JL, Krogh K, et al. The impact of naloxegol on anal sphincter function - using a human experimental model of opioid-induced bowel dysfunction. Eur J Pharm Sci. 2018 May 30;117:187–192. doi: 10.1016/j.ejps.2018.02.008
   PubMed Web of Science ®Google Scholar
• Poulsen JL, Mark EB, Brock C, et al. Colorectal transit and volume during treatment with prolonged-release oxycodone/Naloxone versus oxycodone plus macrogol 3350. J Neurogastroenterol Motil. 2018 Jan 1;24(1):119–127. doi: 10.5056/jnm17058
   PubMed Web of Science ®Google Scholar
• Poulsen JL, Brock C, Grønlund D, et al. Prolonged-release oxycodone/Naloxone improves anal sphincter relaxation compared to oxycodone plus macrogol 3350. Dig Dis Sci. 2017 Nov 1;62(11):3156–3166. doi: 10.1007/s10620-017-4784-7
   PubMed Web of Science ®Google Scholar
• Ouyang R, Li Z, Huang S, et al. Efficacy and safety of peripherally acting mu-opioid receptor antagonists for the treatment of opioid-induced constipation: a Bayesian Network meta-analysis. Pain Med. 2020;21(11):3224–3232. doi: 10.1093/pm/pnaa152
   PubMed Web of Science ®Google Scholar
• Brenner DM, Chey WD. An evidence-based review of Novel and emerging therapies for constipation in patients taking opioid analgesics. Am J Gastroenterol Suppl. 2014;2(1):38–46. doi: 10.1038/ajgsup.2014.8
   Google Scholar
• Drewes AM, Munkholm P, Simrén M, et al. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction–recommendations of the Nordic Working Group. Scand J Pain. 2016;11(1):111–122. doi: 10.1016/j.sjpain.2015.12.005
   PubMedGoogle Scholar
• O’Brien T, Christrup LL, Drewes AM, et al. European pain Federation position paper on appropriate opioid use in chronic pain management. Eur J Pain (United Kingdom). 2017;21(1):3–19. doi: 10.1002/ejp.970
   PubMed Web of Science ®Google Scholar
• Müller-Lissner S, Bassotti G, Coffin B, et al. Opioid-induced constipation and bowel dysfunction: a clinical guideline. Pain Med. 2017;18(10):1837–1863. doi: 10.1093/pm/pnw255
   PubMed Web of Science ®Google Scholar
• Brenner DM, Stern E, Cash BD. Opioid-related constipation in patients with non-cancer pain syndromes: a review of evidence-based therapies and justification for a change in nomenclature. Curr Gastroenterol Rep. 2017;19(3):2–7. doi: 10.1007/s11894-017-0560-2
   PubMedGoogle Scholar
• Manchikanti L. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations. Pain Physician. 2008;11(2):161–186. doi: 10.36076/ppj.2008/11/161
   PubMed Web of Science ®Google Scholar
• Gagliardi AR, Brouwers MC, Palda VA, et al. How can we improve guideline use? A conceptual framework of implementability. Implement Sci. 2011 Mar 22;6(1):1–11. doi: 10.1186/1748-5908-6-26
   PubMedGoogle Scholar
• Erchinger F, Tjora E, Nordaas IK, et al. Pancreatic enzyme treatment in chronic pancreatitis: quality of management and adherence to guidelines–A cross-sectional observational study. United Eur Gastroenterol J. 2022;10(8):844–853. doi: 10.1002/ueg2.12276
   PubMed Web of Science ®Google Scholar
• Bellini M, Tosetti C, Costa F, et al. The general practitioner’s approach to irritable bowel syndrome: from intention to practice. Dig Liver Dis. 2005;37(12):934–939. doi: 10.1016/j.dld.2005.06.011
   PubMedGoogle Scholar
• Bellini M, Gambaccini D, Salvadori S, et al. Management of chronic constipation in general practice. Tech Coloproctol. 2014;18(6):543–549. doi: 10.1007/s10151-013-1093-9
   PubMed Web of Science ®Google Scholar
• Butzlaff M, Kempkens D, Schnee M, et al. German ambulatory care physicians’ perspectives on clinical guidelines – a national survey. BMC Fam Pract. 2006;7(1):1–10. doi: 10.1186/1471-2296-7-47
   PubMedGoogle Scholar
• Burgers JS, Grol RPTM, Zaat JOM, et al. Characteristics of effective clinical guidelines for general practice. Br J Gen Pract. 2003 Jan 1;53(486):15.
   PubMed Web of Science ®Google Scholar
• Michie S, Lester K. Words matter: increasing the implementation of clinical guidelines. BMJ Qual Saf. 2005 Oct 1;14(5):367–370. doi: 10.1136/qshc.2005.014100
   Google Scholar
• Avanzini F, Corsetti A, Maglione T, et al. Simple, shared guidelines raise the quality of antihypertensive treatment in routine care. Am Heart J. 2002 Oct;144(4):726–732. doi: 10.1016/S0002-8703(02)00149-7
   PubMed Web of Science ®Google Scholar
• Ting S. Multicolored simplified asthma guideline reminder (MSAGR) for better adherence to national/global asthma guidelines. Ann Allergy Asthma Immunol. 2002;88(3):326–330. doi: 10.1016/S1081-1206(10)62016-9
   PubMed Web of Science ®Google Scholar
• Wong E, Taylor Z, Thompson J, et al. A simplified gentamicin dosing chart is quicker and more accurate for nurse verification than the BNFc. Arch Dis Child. 2009 Jul;94(7):542–545. doi: 10.1136/adc.2007.137026
   PubMed Web of Science ®Google Scholar
• Cabrera C, Casanova C, Martín Y, et al. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study. Int J Chron Obstruct Pulmon Dis. 2016 Jun 8;11(1):1217–1222. doi: 10.2147/COPD.S100853
   PubMedGoogle Scholar
• Russell K, Addiman S, Grynszpan D, et al. The impact of new national guidance for the public health management of enteric fever in England. Public Health. 2018 Jan 1;154:79–86. doi: 10.1016/j.puhe.2017.10.018
   PubMed Web of Science ®Google Scholar
• Bates AN, Ercolano E. Development and implementation of a simple wound care guideline for minor skin lesions: a quality improvement project. J Wound, Ostomy Cont Nurs. 2021;48(4):285–291. doi: 10.1097/WON.0000000000000778
   PubMed Web of Science ®Google Scholar
• Dahm P, Yeung LL, Gallucci M, et al. How to use a clinical practice guideline. J Urol. 2009;181(2):472–479. doi: 10.1016/j.juro.2008.10.041
   PubMed Web of Science ®Google Scholar